Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 11Anemia, Refractory, with Excess of Blasts 11Neoplasms 9Myelodysplastic Syndromes 8Venous Thromboembolism 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Anemia, Aplastic 5Myeloproliferative Disorders 4Lymphoma, Non-Hodgkin 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hematologic Neoplasms 4Fanconi Anemia 4Anemia 4Pulmonary Embolism 3Primary Myelofibrosis 3Myelodysplastic-Myeloproliferative Diseases 3Multiple Myeloma 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hodgkin Disease 3Congenital Bone Marrow Failure Syndromes 3Burkitt Lymphoma 3Blast Crisis 3Anemia, Sickle Cell 3Venous Thrombosis 2Recurrence 2Neutropenia 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pyruvate Kinase Deficiency of Red Cells × Classical hematology × 30 days × Clear all
NCT04902833 2026-05-19

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

Massachusetts General Hospital

Completed
18 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Pyruvate Kinase Deficiency of Red Cells, Anemia, Hemolytic, Congenital, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡